Sisram Medical Ltd Faces Mixed Mid-Year Results

Sisram Medical Ltd. (HK:1696) has released an update.

Sisram Medical Ltd reported a 1.7% decrease in revenue to US$168.7 million for the first half of 2024, with direct sales now representing 86.1% of total revenue, up from 72.1% in the previous year. Gross profit margin saw a slight increase to 62.4%, but adjusted net profit fell by 19.4% to US$16.7 million. No interim dividend will be declared for the period.

For further insights into HK:1696 stock, check out TipRanks’ Stock Analysis page.